|
Orthologous residues
|
|
DYN1 (human): Y597‑p, DYN1 (mouse): Y597‑p, DYN1 iso3 (mouse): Y597‑p, DYN1 iso4 (mouse): Y597‑p, DYN1 iso6 (mouse): Y593‑p, DYN1 (rat): Y597‑p, DYN1 iso2 (rat): Y597‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, immunoprecipitation, mutation of modification site, western blotting
|
|
Relevant cell lines - cell types - tissues:
293 (epithelial)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
Src (rat)
|
transfection of inactive enzyme, transfection of constitutively active enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
isoproterenol
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
inhibition, molecular association, regulation, receptor internalization, altered
|
|
Comments:
Y231/597F mutant Inhibits B2-AR internalization, and inhibited the isoproterenol mediated activation of ERK2.
|